Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose amitriptyline or mirtazapine for chronic insomnia in general practice
NL-OMON22210Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Insomnia comparing Amitriptyline, Mirtazapine and Placebo (3 arms). Primary endpoint: Insomnia Severity Index total score at 12 months. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
amitriptylinemirtazapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON22210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22210.